Drug recall · December 10, 2025
Nivagen Pharmaceuticals recall
Why: cGMP deviations
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Nivagen Pharmaceuticals, Zinc Oxide Ointment USP, Zinc Oxide 20% Skin Protectant, Net Wt. 15 oz (425g), Made in India, Manufactured for: Nivagen Pharmaceuticals, Inc., Sacramento, CA 95827, USA, NDC 75834-170-15.
- Lots / codes
Lot #: A352318
- Quantity
- 912 containers
- Company
- Blossom Pharmaceuticals, Bardej, Goa
- Distribution
- USA Nationwide
- Initiated
- October 31, 2025 · Voluntary: Firm initiated
- Classified
- December 2, 2025
- Reported
- December 10, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Zinc oxide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.